Startups
2020
APTADEL THERAPEUTICS SLPre-clinical biomedical company focused on development of cancer treatment based on aptamer technology
Main indication is Ewing’s Sarcoma, a rare variety of cancer that affects children.
Main indication is Ewing’s Sarcoma, a rare variety of cancer that affects children.
Address
Carrer de Baldiri Reixac 4, 08028 Barcelona, Spain
Finance Data
CERCA ownership
L'Hospitalet de Llobregat, Spain
2004
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)
CERCA Center Contact
LT
Laia TravesetResponsable innovació
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Aptadel Therapeutics is a European preclinical-stage biotech company located in Barcelona, Spain. We are focused on the development of cancer treatments based on Aptamer technologies. Our lead indication is Ewing Sarcoma, a rare variety of bone cancer, affecting children.
Product description
Development of cancer treatments based on Aptamer technologies